These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19530340)

  • 21. Lupus anticoagulant testing with optical end point automation.
    Luddington R; Scales C; Baglin T
    Thromb Res; 1999 Nov; 96(3):197-203. PubMed ID: 10588462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of lupus anticoagulant by means of dilute Russell's viper venom time is affected by oral anticoagulant therapy.
    Jouhikainen T
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):627-32. PubMed ID: 2133242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Warfarin does not interfere with lupus anticoagulant detection by dilute Russell's viper venom time.
    Olteanu H; Downes KA; Patel J; Praprotnik D; Sarode R
    Clin Lab; 2009; 55(3-4):138-42. PubMed ID: 19462936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical usefulness of the dilute Russell viper venom time test for patients taking warfarin.
    Kanouchi K; Narimatsu H; Ohnuma O; Morikane K; Fukao A
    Int J Hematol; 2017 Aug; 106(2):206-211. PubMed ID: 28390037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dilute Russell's viper venom time reagents in lupus anticoagulant testing: a well-considered choice.
    Depreter B; Devreese KM
    Clin Chem Lab Med; 2017 Jan; 55(1):91-101. PubMed ID: 27331311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring therapy with vitamin K antagonists in patients with lupus anticoagulant: effect on different tests for INR determination.
    Bijsterveld NR; Middeldorp S; Berends F; Büller HR
    J Thromb Thrombolysis; 2000 Apr; 9(3):263-9. PubMed ID: 10728026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Usefulness of silica clotting time for detection of lupus anticoagulants].
    Lee HR; Kim JE; Ha SH; Kim HK; Park S; Cho HI
    Korean J Lab Med; 2009 Dec; 29(6):497-504. PubMed ID: 20046079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lupus anticoagulant testing using two parallel methods detects additional cases and predicts persistent positivity.
    Simmons DP; Herskovits AZ; Battinelli EM; Schur PH; Lemire SJ; Dorfman DM
    Clin Chem Lab Med; 2018 Jul; 56(8):1289-1296. PubMed ID: 27305702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lupus anticoagulants: pathogenesis and laboratory diagnosis.
    Court EL
    Br J Biomed Sci; 1997 Dec; 54(4):287-98. PubMed ID: 9624740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paired APTTs of low and high lupus anticoagulant sensitivity permit distinction from other abnormalities and achieve good lupus anticoagulant detection rates in conjunction with dRVVT.
    Kumano O; Amiral J; Dunois C; Peyrafitte M; Moore GW
    Int J Lab Hematol; 2019 Feb; 41(1):60-68. PubMed ID: 30248243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of six dilute russell viper venom time lupus anticoagulant screen/confirm assay kits.
    McGlasson DL; Fritsma GA
    Semin Thromb Hemost; 2013 Apr; 39(3):315-9. PubMed ID: 23468380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
    Pengo V; Biasiolo A; Rampazzo P; Brocco T
    Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Russell viper venom time (RVVT) test for investigation of lupus anticoagulant (LA).
    Favaloro EJ
    Am J Hematol; 2019 Nov; 94(11):1290-1296. PubMed ID: 31379004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. False-positive lupus anticoagulant in patients receiving rivaroxaban: 24 h since the last dose are needed to exclude antiphospholipid syndrome.
    Góralczyk T; Iwaniec T; Wypasek E; Undas A
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):473-5. PubMed ID: 25402189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new-generation dilute Russell's viper venom time assay system for lupus anticoagulants: evaluation of detection utilising frozen reagents and controls.
    Moore GW; Tugnait S; Savidge GF
    Br J Biomed Sci; 2005; 62(3):127-32. PubMed ID: 16196459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternative assays to dRVVT and aPTT for lupus anticoagulant detection.
    Moore GW
    Am J Hematol; 2020 Aug; 95(8):992-998. PubMed ID: 32311119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants.
    Jourdi G; Delrue M; Stepanian A; Valaize J; Foulon-Pinto G; Demagny J; Duchemin J; Nedelec-Gac F; Darnige L; Curis E; Delavenne X; Gaussem P; Siguret V; Gouin-Thibault I
    Thromb Res; 2019 Dec; 184():86-91. PubMed ID: 31710863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of direct thrombin inhibitors can affect the results and interpretation of lupus anticoagulant testing.
    Genzen JR; Miller JL
    Am J Clin Pathol; 2005 Oct; 124(4):586-93. PubMed ID: 16146819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dilute Russell's viper venom and activated partial thromboplastin time in lupus anticoagulant diagnosis: is mixing essential?
    Chandrashekar V
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):408-11. PubMed ID: 26626041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.